These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9308942)

  • 1. Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy.
    Wazer DE; Kramer B; Schmid C; Ruthazer R; Ulin K; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):381-93. PubMed ID: 9308942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.
    Wazer DE; Schmidt-Ullrich RK; Ruthazer R; Schmid CH; Graham R; Safaii H; Rothschild J; McGrath J; Erban JK
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):851-8. PubMed ID: 9531370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy.
    Neuschatz AC; DiPetrillo T; Safaii H; Price LL; Schmidt-Ullrich RK; Wazer DE
    Cancer; 2003 Jan; 97(1):30-9. PubMed ID: 12491502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosmetic outcome in patients receiving an interstitial implant as part of breast-conservation therapy.
    Kramer BA; Arthur DW; Ulin K; Schmidt-Ullrich RK; Zwicker RD; Wazer DE
    Radiology; 1999 Oct; 213(1):61-6. PubMed ID: 10540641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
    Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
    Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
    Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.
    Hattangadi JA; Powell SN; MacDonald SM; Mauceri T; Ancukiewicz M; Freer P; Lawenda B; Alm El-Din MA; Gadd MA; Smith BL; Taghian AG
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):791-800. PubMed ID: 22099046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing cosmetic results after conservation therapy for breast cancer.
    Taylor ME; Perez CA; Halverson KJ; Kuske RR; Philpott GW; Garcia DM; Mortimer JE; Myerson RJ; Radford D; Rush C
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):753-64. PubMed ID: 7860386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
    Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.
    Wazer DE; Lowther D; Boyle T; Ulin K; Neuschatz A; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):107-11. PubMed ID: 11316552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
    Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer].
    Bayerl A; Frank D; Lenz A; Höss C; Lukas P; Feldmann HJ; Molls M
    Strahlenther Onkol; 2001 Jan; 177(1):25-32. PubMed ID: 11200109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancer.
    Sharma DN; Deo SV; Rath GK; Shukla NK; Thulkar S; Madan R; Julka PK
    Tumori; 2013; 99(5):604-10. PubMed ID: 24362865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.